ES2073277T3 - Sustancias de naturaleza polipeptida utiles en la terapia humana. - Google Patents

Sustancias de naturaleza polipeptida utiles en la terapia humana.

Info

Publication number
ES2073277T3
ES2073277T3 ES92900285T ES92900285T ES2073277T3 ES 2073277 T3 ES2073277 T3 ES 2073277T3 ES 92900285 T ES92900285 T ES 92900285T ES 92900285 T ES92900285 T ES 92900285T ES 2073277 T3 ES2073277 T3 ES 2073277T3
Authority
ES
Spain
Prior art keywords
venues
substances
human therapy
useful polypeptide
induce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92900285T
Other languages
English (en)
Inventor
Alberto Bartorelli
Angela Turiano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zetesis SpA
Original Assignee
Zetesis SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis SpA filed Critical Zetesis SpA
Application granted granted Critical
Publication of ES2073277T3 publication Critical patent/ES2073277T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SUSTANCIAS DE POLIPEPTIDA NATURAL OBTENIBLE POR EXTRACCION DE TEJIDOS HOMOGENEOS ANIMALES, CUYAS SUSTANCIAS PUEDEN INDUCIR, CUANDO SE ADMINISTRAN A VARIAS ESPECIES ANIMALES, LA FORMACION DE ANTICUERPOS VALIDOS PARA RECONOCER EN VIVO O EN VITRO ANTIGENOS, LOS CUALES ESTAN PRESENTES EN CELULAS TUMORALES HUMANAS; Y PUEDEN REDUCIR O INHIBIR EL DOLOR, INDUCIR UN EFECTO DE LISIS CELULAR, E INHIBIR O REDUCIR EL CRECIMIENTO DEL TUMOR, CUANDO SE ADMINISTRA A HUMANOS AFECTADOS POR TUMORES MALIGNOS DE DIFERENTES CLASES.
ES92900285T 1990-12-11 1991-12-09 Sustancias de naturaleza polipeptida utiles en la terapia humana. Expired - Lifetime ES2073277T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.

Publications (1)

Publication Number Publication Date
ES2073277T3 true ES2073277T3 (es) 1995-08-01

Family

ID=11194931

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92900285T Expired - Lifetime ES2073277T3 (es) 1990-12-11 1991-12-09 Sustancias de naturaleza polipeptida utiles en la terapia humana.

Country Status (16)

Country Link
US (1) US5824640A (es)
EP (1) EP0574394B1 (es)
JP (1) JP3213942B2 (es)
KR (1) KR100196028B1 (es)
AT (1) ATE122890T1 (es)
AU (1) AU661287B2 (es)
CA (1) CA2098113C (es)
CZ (1) CZ283037B6 (es)
DE (1) DE69110060T2 (es)
DK (1) DK0574394T3 (es)
ES (1) ES2073277T3 (es)
HU (1) HU217615B (es)
IT (1) IT1244879B (es)
NO (1) NO308396B1 (es)
RU (1) RU2113224C1 (es)
WO (1) WO1992010197A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
RO117590B1 (ro) * 1995-02-03 2002-05-30 Aeterna Lab Inc Compozitie pentru tratamentul unei degenerari, boli colagenice sau inflamatorii
IT1276707B1 (it) * 1995-06-13 1997-11-03 Zetesis Spa Composizioni farmaceutiche ad attivita' analgesica
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
IT1284524B1 (it) * 1996-09-13 1998-05-21 Zetesis Spa Uso di proteine come agenti anti-retrovirali
RU2196606C2 (ru) 1996-09-18 2003-01-20 Зетесис С.п.А. Применение белков в качестве агентов против аутоиммунных заболеваний
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
US20030162704A1 (en) * 2000-06-08 2003-08-28 Alberto Panerai Method of treatment of parkison's disease with a protein extractable from mammalian organs
WO2001093888A2 (en) * 2000-06-08 2001-12-13 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
RU2211700C2 (ru) * 2001-07-23 2003-09-10 Научно-исследовательский институт медико-биологических проблем Республики Северная Осетия-Алания Способ получения лекарственного препарата "скваакан"
ITMI20022307A1 (it) * 2002-10-30 2004-04-30 Zetesis Spa Associazioni anti-tumorali comprendenti proteine e chemioterapici.
EP1713502A1 (de) * 2004-02-12 2006-10-25 MERCK PATENT GmbH Hochkonzentrierte, flüssige formulierungen von anti-egfr-antikörpern
RU2292393C2 (ru) * 2005-03-03 2007-01-27 Закрытое акционерное общество "Научно-производственное предприятие "Тринита" Способ получения ингибитора коллагеназы из гепатопанкреаса промысловых видов краба

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
EP0149468B1 (de) * 1984-01-12 1990-10-31 SYMBIOTEC Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie GmbH Biologisch wirksame Substanz mit hormonellen Eigenschaften, Verfahren zu ihrer Herstellung und Verwendung von Histonen für medizinische Zwecke
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド

Also Published As

Publication number Publication date
NO932101D0 (no) 1993-06-09
IT9022341A0 (it) 1990-12-11
IT9022341A1 (it) 1992-06-11
CA2098113C (en) 2002-02-05
DE69110060D1 (de) 1995-06-29
KR100196028B1 (ko) 1999-06-15
NO932101L (no) 1993-08-10
AU661287B2 (en) 1995-07-20
JP3213942B2 (ja) 2001-10-02
CZ283037B6 (cs) 1997-12-17
HU9301677D0 (en) 1993-09-28
AU9035791A (en) 1992-07-08
IT1244879B (it) 1994-09-12
WO1992010197A1 (en) 1992-06-25
CA2098113A1 (en) 1992-06-11
ATE122890T1 (de) 1995-06-15
NO308396B1 (no) 2000-09-11
EP0574394B1 (en) 1995-05-24
CZ111693A3 (en) 1994-04-13
EP0574394A1 (en) 1993-12-22
DK0574394T3 (da) 1995-10-16
HU217615B (hu) 2000-03-28
JPH06504039A (ja) 1994-05-12
HUT64569A (en) 1994-01-28
US5824640A (en) 1998-10-20
RU2113224C1 (ru) 1998-06-20
DE69110060T2 (de) 1995-09-28

Similar Documents

Publication Publication Date Title
EP1146046A3 (en) Pyropheophorbides and their use in photodynamic therapy
EP0425566A4 (en) New photosensitizing agents
ES2004843T3 (es) Procedimiento de obtencion de un equivalente de piel y equivalente de piel correspondiente.
ES2075019T3 (es) Anticuerpos monoclonales especificos del receptor del factor de crecimiento de la epidermis humana y composiciones terapeuticas que los contienen.
ES2136673T3 (es) Utilizacion del factor de crecimiento de los queratinocitos para la obtencion de medicamentos.
IT1077901B (it) Stimolatore di tessuto vivente di tipo impiantabile
NO890089D0 (no) Fremgangsmaater for stimulering av haarvekst.
BR7504001A (pt) Artigos cirurgicos implantaveis,utilizaveis em cirurgia humana ou animal,total ou parcialmente bioresorbaveis
CY1105634T1 (el) Η χρηση του ραδιου -223 για τη στοχευση ασβεστωμενων ιστων για την ανακουφιση πονου και τη θεραπεια οστικου καρκινου
ES2069750T3 (es) Metodos y composiciones para curar huesos.
DK0574394T3 (da) I den humane terapi anvendelige stoffer af polypeptidnatur
RU93042874A (ru) Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии
ES2150902T3 (es) Procedimientos para potenciar la cicatrizacion de heridas y la reparacion de tejidos.
AR016254A1 (es) Una composicion de celulas de tumor modificadas con un hapteno o extracto de celulas tumorales y uso de la misma en la elaboracion de un medicamento.
Dougherty et al. Photoradiation therapy of malignant tumors; role of the laser
Veliath et al. Malignant Pilomatrixoma Report of a Case
HU9201197D0 (en) Protection from shock subsequent to injury by double-stranded rns
Frieden et al. Effect of Administration of Intermedin upon Melanin Content of the Skin of Rana pipiens.
AR023726A1 (es) Terapia con gch para el tratamiento del cancer de mama
谢大任 Treatment of Cancer
WO1996012019A3 (en) Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family
HAYAKAWA Description of Haematopota shinonagai n. sp. from Honshu Island, Japan (Diptera, Tabanidae)
Jemec Pre-operative traumatic congestion and composite skin-fat grafting: An experimental study
ES2052499T3 (es) Complejos de (gem-heterociclodimenatamina-n,n') platino.
MX9307736A (es) Nuevas triazoloquinazolinas, su obtencion y uso.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 574394

Country of ref document: ES